RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Published:2023-05-30 Issue:6 Volume:15 Page:1623
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Zhou Shiwei¹²³^ORCID,Obianom Obinna N.²,Huang Jiangsheng³,Guo Dong²,Yang Hong²,Li Qing¹^ORCID,Shu Yan¹²

Affiliation:

1. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China

2. Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA

3. Department of Thyroid Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China

Abstract

The authors and the journal retract the article, ‘Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation’ [...]

Funder

National Science and Technology Major Project

U.S. Food and Drug Administration

Key Technologies Research and Development Program

Publisher

MDPI AG

Subject

Pharmaceutical Science

Link

https://www.mdpi.com/1999-4923/15/6/1623/pdf

Reference1 articles.

1. Zhou, S., Obianom, O.N., Huang, J., Guo, D., Yang, H., Li, Q., and Shu, Y. (2021). Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics, 13.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP